https://www.selleckchem.com/pr....oducts/glumetinib.ht
Hypercoagulability and the need for prioritizing coagulation markers for prognostic abilities have been highlighted in COVID-19. We aimed to quantify the associations of D-dimer with disease progression in patients with COVID-19. This systematic review and meta-analysis was registered with PROSPERO, CRD42020186661.We included 113 studies in our systematic review, of which 100 records (n = 38,31 with D-dimer data) were considered for meta-analysis. Across 68 unadjusted (n = 26,96 and 39 adjusted studies (n = 15,653) reporting init
Like
Comment
Share
